Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Shoshana Rosenberg, ScD, MPH
CONTACT
Darima Dorzhieva
CONTACT
Lead
Weill Medical College of Cornell University
With
Primary objectives: * To test the effectiveness of the CONSYDER decision support tool on reducing decisional conflict prior to breast cancer surgery. * To evaluate the implementation of and mechanisms of use for CONSYDER. Secondary Objectives: * To determine the impact of CONSYDER on decision-making preferences, breast cancer knowledge, treatment goals and preferences, anxiety, decisional regret, and self-efficacy in communication. Exploratory Objectives: * To explore whether CONSYDER impacts surgical choice. OUTLINE: This is a multi-site cluster randomized trial using a stepped wedge design. Approximately 800 women will be recruited at 4 study sites (Weill Cornell Medicine, Yale Cancer Center, Dana-Farber Cancer Institute, Duke Cancer Institute), including network affiliate sites, over an approximate 30-month period. All sites will have a 6-month "run-in" period where patients will not be sent CONSYDER. The 6-month blocks may be extended if recruitment targets are not met. Sites will be randomized to begin delivery of CONSYDER to all newly diagnosed women, age ≤44, with Stage 0-III breast cancer as part of routine clinical care; young women will have access to the website whether or not they consent to research study participation.
Age
18–44
Sex
FEMALE
Healthy volunteers
Not accepted